Microbot Medical Inc (MBOT)

Currency in USD
2.542
-0.048(-1.86%)
Real-time Data·
MBOT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4402.560
52 wk Range
1.2504.670
Key Statistics
Prev. Close
2.59
Open
2.54
Day's Range
2.44-2.56
52 wk Range
1.25-4.67
Volume
1.36M
Average Vol. (3m)
2.38M
1-Year Change
62.1019%
Book Value / Share
1.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBOT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.500
Upside
+195.04%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Microbot Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Microbot Medical Inc Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Compare MBOT to Peers and Sector

Metrics to compare
MBOT
Peers
Sector
Relationship
P/E Ratio
−12.9x−2.8x−0.6x
PEG Ratio
−0.27−0.020.00
Price / Book
2.2x4.1x2.6x
Price / LTM Sales
-3.3x3.3x
Upside (Analyst Target)
112.4%38.9%44.5%
Fair Value Upside
Unlock6.3%5.0%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.500
(+195.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy12.00+371.51%-MaintainFeb 26, 2026
B.Riley
Buy5.00+96.46%-New CoverageFeb 10, 2026
Roth/MKM
Buy5.50+116.11%-New CoverageDec 03, 2025
H.C. Wainwright
Buy12.00+371.51%-MaintainNov 28, 2025
H.C. Wainwright
Buy12.00+371.51%-MaintainNov 21, 2025

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-0.06 / -0.07
Revenue / Forecast
40.00K / 300.00K
EPS Revisions
Last 90 days

MBOT Income Statement

People Also Watch

2.1600
SIDU
+4.35%
9.700
RDW
+12.53%
10.390
ONDS
+0.87%
43.740
IREN
-0.66%
12.904
RCAT
+3.89%

FAQ

What Is the Microbot Medical (MBOT) Stock Price Today?

The Microbot Medical stock price today is 2.542 USD.

What Stock Exchange Does Microbot Medical Trade On?

Microbot Medical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Microbot Medical?

The stock symbol for Microbot Medical is "MBOT."

What Is the Microbot Medical Market Cap?

As of today, Microbot Medical market cap is 169.840M USD.

What Is Microbot Medical's Earnings Per Share (TTM)?

The Microbot Medical EPS (TTM) is -0.393.

When Is the Next Microbot Medical Earnings Date?

Microbot Medical will release its next earnings report on May 12, 2026.

From a Technical Analysis Perspective, Is MBOT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Microbot Medical Stock Split?

Microbot Medical has split 4 times.

How Many Employees Does Microbot Medical Have?

Microbot Medical has 20 employees.

What is the current trading status of Microbot Medical (MBOT)?

As of Feb 26, 2026, Microbot Medical (MBOT) is trading at a price of 2.542 USD, with a previous close of 2.590 USD. The stock has fluctuated within a day range of 2.440 USD to 2.560 USD, while its 52-week range spans from 1.250 USD to 4.670 USD.

What Is Microbot Medical (MBOT) Price Target According to Analysts?

The average 12-month price target for Microbot Medical is 7.500 USD, with a high estimate of 12 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +195.04% Upside potential.

What Is the MBOT Premarket Price?

MBOT's last pre-market stock price is 2.550 USD. The pre-market share volume is 93,940.000, and the stock has decreased by -0.040, or -1.540%.

What Is the MBOT After Hours Price?

MBOT's last after hours stock price is 2.620 USD, the stock has decreased by 0.030, or 1.160%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.